sellWeak cluster of 310b5-1 plan
Blum Robert I sold $258k of CYTK
President & CEO at CYTOKINETICS INC. 5,000 shares at an average of $51.63, traded Nov 1, 2024, filed Nov 4, 2024.
Warning score
18Value
$258k
5,000 shares
Holdings after
397,456
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-026397, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | MOption exercise Common Stock10b5-1 | +5,000 | $6.67 | $33k | 402,456 | Nov 4, 2024 |
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -5,000 | $51.63 | $258k | 397,456 | Nov 4, 2024 |
| Nov 1, 2024 | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 64,727 | Nov 4, 2024 |
Related signals
Other insiders at CYTOKINETICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 40Moderate | sell 310b5-1 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $611k | 15,000 | |
| 4Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Malik Fady Ibraham EVP Research & Development | $87k | 2,000 | |
| 45Moderate | sell 410b5-1 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $1.1M | 25,000 | |
| 59Moderate | sell 4 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $561k | 12,648 | |
| 29Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Callos Andrew EVP, Chief Commercial Officer | $943k | 20,900 | |
| 42Moderate | sell 4 | CYTK CYTOKINETICS INC | Malik Fady Ibraham EVP Research & Development | $195k | 4,389 | |
| 40Moderate | sell 4 | CYTK CYTOKINETICS INC | Callos Andrew EVP, Chief Commercial Officer | $123k | 2,775 | |
| 0Weak | sell 410b5-1 | CYTK CYTOKINETICS INC | Callos Andrew EVP, Chief Commercial Officer | $4,500 | 100 | |
| 45Moderate | sell 410b5-1 | CYTK CYTOKINETICS INC | Callos Andrew EVP, Chief Commercial Officer | $1.2M | 26,771 | |
| 61Notable | sell 4 | CYTK CYTOKINETICS INC | Blum Robert I President & CEO | $737k | 16,970 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.